The delivery of proteins has been regarded as the safest and most useful application in therapeutic application of Stem Cells, because proteins can regulate gene expression transiently without any genomic alteration.
Prostates olypeptides are composed of regulatory proteins, which acts selectively on prostate cells promoting the recovery of prostate functions.
Polypeptides are administered in the form of a rectal bolus that dissolves at body temperature.
This reduces the amount of lecithin granules in acini and normalizes secretory function of epithelial cells. Prostatilen peptides are used in chronic prostatitis, adenoma, excretory-toxic infertility, complications after prostate surgery, also for age-related degeneration of prostate function.
The preparations supply substances that may be deficient in the corresponding organ in vivo, including nuclei acids and organ-specific enzymes, glycosaminoglycans; glycolipids and phospholipids; enzyme cofactors; mineral storage proteins and other organic substances.
The specificity of cell structure and function is conferred by the amino acid sequences of proteins and the nucleotide sequences of nucleic acids. Chromosomes are composed of DNA condensed around a protein core of histones (the nucleosome), which is the first level of chromatin organization. Nucleosomes self-assemble from DNA and histones in the presence of nucleoplasmin, (an acidic protein that acts as a molecular chaperone to bring histones and DNA), plus DNA topoisomerase. The nucleus exports information to the cytoplasm, as messenger and transfer RNAs. Thus, specificity and organization are controlled by DNA/protein interactions.
Patients with chronic prostatopathy have often complain of sexual dysfunction in terms of a shortened time of ejaculation. In this regard, the identified ability of prostatilen to sexual function of a patient is very important.
Study of ejaculate was conducted 7-10 days after administration. As a result, there was an increase in ejaculate volume, restoration of normal sperm count, as in oligo- and during polizoospermia, and in the ratio of mobile and fixed forms. At the same time, there was a decrease of activity of cells agglutination.
In another study there was a decrease of pathological forms after treatment in patients with chronic prostatitis, reduced prostate adenoma, congestive-inflammatory processes and fibrous-calcified sites.
Peptide medicine also consist of a proprietary blend of Polypeptides with Organosulfur in the form of Dimethyl sulfoxide.
Dimethyl sulfoxide is an anti-inflammatory and analgesic compound that holds promise in managing a wide range of debilitating health conditions. It is an approved pharmacological agent in more than 125 countries, and its safety and therapeutic effects are backed by nearly 50 years of research and more than 10,000 scientific articles on its biological implications. Dimethyl sulfoxide is frequently used as a carrier in antiviral therapies because of its ability to easily enter affected cells. The organosulfur compound has shown to inhibit Propionibacterium in bacterial prostatitis and inflammation of the prostate leading to cancer.
A protective role for vitamin K with respect to advanced prostate cancer was already found in the Heidelberg cohort of the EPIC study. This hypothesis can be further evaluated in studies examining the connection between vitamin K and varicoceles, and also by examining the connection between varicoceles and benign prostate hyperplasia.
Its also important to note the clinical presentation of IgG4 inflammatory disease is similar to that in benign prostatic hyperplasia or chronic prostatitis.
Immunoglobulin G4-related disease (IgG4-RD) is a recently described inflammatory disease involving multiple organs. Prostate involvement with IgG4-RD is very rare. A proportion of patients currently diagnosed with prostatic hyperplasia or CP/CPPS might in fact be suffering from a monosymptomatic disease manifestation of IgG4-related prostatitis. It is imperative to make this an important entity to diagnose correctly to avoid misdiagnosis and unnecessary surgeries. There’s also an increased risk of IgG4-RD due to immune dysregulation caused by cancer treatment such as chemotherapy and radiation.
Notably, the antioxidant potential of Pituitary Polypeptides in nontumorigenic human prostate epithelial cells (RWPE-1) is viable. Treatment of RWPE-1 cells with (50 microg/ml) provided significant protection against H(2)O(2)-induced cell death, deoxyribonucleic acid fragmentation, protein oxidation, and membrane damage. Pituitary polypeptide extract provides remarkable protection against oxidative stress in human prostate epithelial cells.
Further Options with Stem Cell Therapy::
a) Biophysical Oxidative Therapy.
b) Homeopathic Ampoule treatment: for the improvement of lymphatic drainage, the non-specific immune defense, for benign hypertrophy.
Please do not misconstrue any information listed on this site as a substitute for medical advice. The information presented here is not intended to replace medical advice.